Olcayto Guelec and David Geuder diseinatzailearen Vivos Lehen Funtzioa: Oftalmologia Kirurgia Sistema

Olcayto Guelec and David Geuder diseinatzailearen Vivos Lehen Funtzioa: Oftalmologia Kirurgia Sistema lana 2026 Urrezko Saria A' Design Award sari ospetsuaren irabazle bikaina da Gailu Mediko eta Ekipamendu Medikoaren Diseinua Lehiaketa Kategorian.

UrreProduktu Medikoa· 2026

Vivos Lehen Funtzioa: Oftalmologia Kirurgia Sistema

diseinatzailea: Olcayto Guelec and David Geuder

Bezeroa: Geuder AG

Urrezko Saria A' Design Award Irabazlea Produktu Medikoa Kategorian

56,783

Egiaztatutako Sari Irabazlea

#182492 Sariaren Egoera Egiaztatu

A' Design Award-en Ikusi Prentsa-oharra Sari-bereizgarria

Koloreak

Diseinua

Vivos Lehen Funtzioa: Oftalmologia Kirurgia Sistema Diseinuari Buruz

Vivos-ek kirurgia lanpostua birdefinitzen du anbizio klinikoarekin batera bilakatzen den plataforma gisa. Hiru konfigurazioek —Core, Nova eta Nova+— gaitasuna zabaltzen dute sistema ordezkatu beharrik gabe, oftalmologia kirurgiako bere motako eguneratze-arkitektura bakarra izanik. Interfaze bakar batek, aurretiko prestakuntzarik gabe lehen erabileran ehuneko 91,7ko asebetetzea baliozkotua duenak, prozeduraren inguruan baino kirurgialariaren inguruan eraikitako diseinua islatzen du. Argiztatutako tresna-konexioek, material findu eta xehetasun neurtuek presentzia lasai eta konfiantzazkoa ematen diote gailuari, kategoria honetan ohikoa den zarata bisualetik libre.

Aintzatespena

Urrezko Saria A' Design Award Sariari Buruz

Vivos Lehen Funtzioa: Oftalmologia Kirurgia Sistema Urrezko Saria A' Design Award irabazlea da, lehen mailako, zoragarriak eta nabarmenak diren diseinuei ematen zaien aitorpen izugarri prestijiotsua. Urre-mailako irabazleak berrikuntzaz beteriko, ikuspegi handiko eta distiraz liluragarriak diren sorkuntzak dira, beren diseinatzaileen genioa, jakituria eta trebetasuna islatzen dutenak. Vivos Lehen Funtzioa: Oftalmologia Kirurgia Sistema oso goraipatua, joera-markatzailea eta monumentala den asmakizuna izatea espero da, balio aurrekaririk gabea eskaintzen duena. Urrezko Saria A' Design Award irabazi duen diseinu hau proiektu ikusgarri eta errespetatua da, artearen, zientziaren, diseinuaren eta teknologiaren mugak oso onuragarriro zabaltzen dituena. Vivos Lehen Funtzioa: Oftalmologia Kirurgia Sistema desira-sentimendu biziak sortzen dituen, grina pizten duen, sormena bultzatzen duen eta liluratzen gaituen lana da.

Diseinuaren Atzean

Prentsa-kita

Diseinatzaileak emandako kredituak, taldekideak eta xehetasun teknikoak.

Propietate Bereziak: Vivos is the only ophthalmic surgery system that grows with clinical needs. Core for cataract. Nova adds vitrectomy. Plus adds laser. One platform. One interface. One training investment. Independent usability validation confirmed 92 percent user satisfaction among first time users. Illuminated connection sockets were rated positively by all study participants. Premium materials and restrained detailing give the device a likeable presence without the visual noise typical of the category.
Neurriak eta Ontziratzea: Display: 24 inch capacitive touchscreen. Vitrectomy: up to 40000 cuts per min. Vacuum: up to 700 mmHg, highest in category. Phacoemulsification: 53 kHz piezoelectric. IOP: active real-time (VIVOS Balance). Endolaser: 532 nm. Illumination: SOLEA LED, 16.9M colours, 2 ports, Retina Protection Mode. CE pending, submitted Feb 2026. ISO 13485 2016.
Etiketak: Ophthalmic Surgery System, Medical Device Design, Phacoemulsification, Vitrectomy, Modular Medical Platform, Surgical Ergonomics, Workflow Design, German Medical Engineering, Usability Validation, Premium Medical Aesthetics
Produkzio Teknologia: Medical-grade polycarbonate housing, antimicrobial surface coating rated for over 10,000 disinfection cycles. Piezoelectric phacoemulsification at 53 kHz with beveled-up probe geometry for optimised fluidics. Pneumatic vitrectomy probe up to 40,000 cuts/min. IEC 60601-1 compliant. Modular quick-change cassette - single or multi-patient - tool-free exchange. Compatible with older phaco handpieces, protecting prior investment. Individually assembled in Heidelberg. ISO 13485:2016, IEC 62366-1, IEC 60601-1, CE pending
Diseinu Erronka: The central challenge was integrating six surgical functions, historically distributed across two to three separate devices, into a single platform without increasing cognitive load. Internally, decades of segmented product architecture and a 75-year heritage required rethinking established engineering logic. Externally, MDR regulations, IEC 62366 1 usability standards and strict OR hygiene constraints limited design freedom. Maintaining identical UX across Core, Nova and Plus while ensuring durability for thousands of cleaning cycles demanded systemic redesign rather than incremental improvement.
Ikerketa: Usability research was conducted. Objective: reduce cognitive load without limiting clinical capability. Methodology: iterative co-design workshops with surgeons, Geuder teams and engineering, followed by independent summative validation per IEC 62366-1. Data collection included usability testing and task-based evaluations. Participants: 13 first-time users at RWTH Aachen University, 2026. Results: 91.7% satisfaction, no unacceptable residual risks. Insights validated the workflow UI, surgeon profiles and illuminated sockets, contributing to greater efficiency, improved patient safety and long-term system adoption in clinical practice.
Inspirazioa: Ophthalmic surgery is precise. Why should its devices remain fragmented, complex and visually uninspiring. Anterior and posterior procedures require separate investments, training and ecosystems not because clinical need requires it but because no manufacturer redesigned the architecture around the surgeon. Geuder AG with seventy five years of ophthalmic expertise asked what if one platform could grow without hardware replacement. Validated by independent study and unique in its modular upgrade logic.
Proiektuaren Iraupena: The project was developed in Heidelberg, Germany by Geuder AG. Development spanned multiple months with iterative design and engineering phases conducted in close collaboration with ophthalmic surgeons and operating room nursing staff. Summative usability validation was performed at RWTH Aachen University in early 2026. CE Mark application was submitted on 27 February 2026. Public market launch is scheduled for June 2026.
Eragiketa Fluxua: Before each procedure, the surgeon selects a personal profile, preloading preferred settings and pedal sensitivity. A three-column touchscreen maps each surgical step as a visual sequence. Colour-coded modules allow instant identification in a darkened theatre. Illuminated sockets guide instrument connection by touch. The foot pedal, with individually adjustable actuation force, controls fluid flow and laser hands-free. Eye pressure is monitored and adjusted in real time.
Taldekideak: Collaboration between Geuder AG's Engineering, Quality Management, Regulatory Affairs, Product Management, Service, Application, Development, and Sales departments.
Irudi Kredituak: Photography Geuder AG, 2026